Research focus: Leukemia and leukemia biology and radiation epidemiology.
An Examination of IRF8 as a Biomarker of aging, Malignant Transformation, and Prognosis
Integrating Diagnostics with Therapeutic Strategies in Chronic Myeloid Leukemia
Proteomic Signatures Associatedd with Complete Response and Complete Continuous Response at One Year Following Cytarabine-based Induction Chemotherapy in Younger Adult Patients (18-60 Years of age) with a Newly Diagnosed Non-M3 AML
Cancer Mortality among Military Participants at US Nuclear Weapons Tests
Functional Methods for Radiation Exposure and Biomarker Data